Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assay
about
How to Define the Latent Reservoir: Tools of the TradePilot studies for development of an HIV subtype panel for surveillance of global diversity.Development of a contemporary globally diverse HIV viral panel by the EQAPOL programCross-platform analysis of HIV-1 RNA data generated by a multicenter assay validation study with wide geographic representation.Technical and regulatory shortcomings of the TaqMan version 1 HIV viral load assayMolecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays.Initiation of antiretroviral therapy at high CD4+ cell counts is associated with positive treatment outcomes.Single real-time reverse transcription-PCR assay for detection and quantification of genetically diverse HIV-1, SIVcpz, and SIVgor strains.Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settings.Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1.HIV-1 load comparison using four commercial real-time assaysComparison of the COBAS/Ampliprep Taqman and Amplicor HIV-1 monitor tests in Lagos, Nigeria.
P2860
Q26766705-3D0417CF-5741-4461-8C83-7BE37D2F468DQ30514155-0600AAE2-7BA5-4E0C-8751-BD1BFC0D6267Q33922689-0225A8EB-1FC7-4812-BC95-2C97577F2E91Q34301929-CC341A6F-A053-4A17-945E-764FF20FF0ABQ34399511-FADCF452-D33C-4B21-839F-72714FE65F7EQ35356381-9E0DA161-25A4-4190-8734-E122BFB1BB8DQ36070585-6C67597A-295E-40F0-AAB6-03D9432919CDQ36667567-0C9B3D60-54A4-4C4F-B7AE-0D82211159A8Q37157278-E9482109-C835-4FF9-8894-FE72CF768DD3Q38088726-0666EB29-FC66-4150-9FCE-5474DE79DF0FQ42113208-D3AD0111-D9F7-482D-B3A8-7F49E36F9E83Q45045900-51E52DC2-C91B-4B20-B771-636B08E95AD0
P2860
Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assay
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Correction of underquantificat ...... s AmpliPrep/Cobas TaqMan assay
@ast
Correction of underquantificat ...... s AmpliPrep/Cobas TaqMan assay
@en
type
label
Correction of underquantificat ...... s AmpliPrep/Cobas TaqMan assay
@ast
Correction of underquantificat ...... s AmpliPrep/Cobas TaqMan assay
@en
prefLabel
Correction of underquantificat ...... s AmpliPrep/Cobas TaqMan assay
@ast
Correction of underquantificat ...... s AmpliPrep/Cobas TaqMan assay
@en
P2093
P2860
P356
P1476
Correction of underquantificat ...... s AmpliPrep/Cobas TaqMan assay
@en
P2093
C Liesnard
D Marissens
L Debaisieux
S Van den Wijngaert
P2860
P304
P356
10.1128/JCM.01226-09
P407
P577
2010-02-17T00:00:00Z